CT
CVS icon

ClearAlpha Technologies’s CVS Health CVS Stock Holding History

ClearAlpha Technologies’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,235
Closed -$418K – 265
2024
Q1 		$418K Buy
+5,235
New +$400K 0.18% 179

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearAlpha Technologies's CVS Position: Q2 2024 in Review

ClearAlpha Technologies sold out of CVS Health (CVS) in Q2 2024, closing a stake of 5,235 shares — an estimated $418K sold.

ClearAlpha Technologies first reported a position in CVS in Q1 2024 and held it in 1 quarter. The position peaked at $418K in Q1 2024. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • ClearAlpha Technologies reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • ClearAlpha Technologies sold 5,235 CVS Health shares in Q2 2024, an estimated $418K.
  • ClearAlpha Technologies first reported a position in CVS Health in Q1 2024 and held it in 1 quarter.
  • ClearAlpha Technologies's CVS Health position peaked at $418K in Q1 2024.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on ClearAlpha Technologies's 13F filing for Q2 2024, filed 13 Aug 2024.